The FDA approved the drug Remdesivir for infants as young as 4 weeks old. COVID-19 pediatric infections have climbed 43% from two weeks ago.

The FDA approved the drug Remdesivir for infants as young as 4 weeks old. COVID-19 pediatric infections have climbed 43% from two weeks ago.